Moderna's Early COVID-19 Vaccine Trials Show Promising Results
There was some good news in the fight against coronavirus on Monday as drug maker Moderna said that its vaccine induced immune responses in healthy volunteers in a clinical study. The volunteers made antibodies that matched or exceeded the levels found in patients who had recovered after contracting the virus. Moderna will now move into Phase 2 trials with more people involved in that study and then Phase 3 they hope to begin in July. Moderna ultimately hopes to have something ready by the fall, but we are still some time away from having a vaccine to be distributed widely. I'll tell you what you need to know.
Learn more about your ad-choices at https://news.iheart.com/podcast-advertisers